Dr. Hugo Caicedo is a Sr. Director in the Accelerated R&D Leadership Program at Eli Lilly and Company. His current role is within the Clinical Laboratory Sciences organization in support of drug development and decentralized clinical trials. He is part of an elite group of emerging leaders with strong acumen in biomedical sciences, clinical development, and business management. With strong sponsorship from C-Suite Executives, they contribute to shaping and executing Lilly’s long-term growth strategy.
I hold a Ph.D. in Biomedical Engineering (focused on Molecular Neuroscience) from the University of Illinois at Chicago & Sorbonne Université in Paris, a postdoctoral research fellowship from Harvard Medical School, and a Fellowship in Business Administration from MIT. My bachelor was in engineering from the Universidad del Valle in Cali (Colombia), but I never practiced engineering. In graduate school, I got more interested in biomedical sciences and their applications to human biology, human health, and preventive medicine. Overall, I am interested in the intersection of enterprise strategy and R&D.
I work at Eli Lilly and Company. A focused biopharma company that creates medicines that make life better for people around the world. Our four focused areas are Obesity, Diabetes and Metabolism; Neuroscience; Oncology; and Immunology.
I am also interested in history. In 1982, Lilly gave birth to the Biotech industry with the first ever commercially approved biologic: Human insulin.
The purpose of the company. Today, once again, Lilly is rewriting medical history with modern science and solutions for clinical medicine. I also like the emphasis on Diversity, Equity, and Inclusion in everything we do.
A set of hard and soft skills. Hard skills include topnotch technical knowledge and subject-matter expertise. Soft skills include EQ, perspective, mindset, cultural openness, resocialization flexibility. All of which have informed and shaped my leadership style. I chose this role because I feel I am equipped to make an impact and I want to continue my leadership journey with the best professionals in the best environment in the biopharma industry.
Success is not a zero-sum competition with winners and losers. Success is a win-win situation where all key stakeholders win. Depending on the context, key timed-bound performance indicators need to be defined and measured against a baseline.
Three things: The purpose of the company, the opportunity for career progression, and the people I work with.
First off, be kind. Then, be ambitious. Identify your purpose in life sooner than later; recognize your strengths, weaknesses, and close the gap; don’t be afraid of making mistakes; learn from those mistakes -quickly- and don’t repeat them; find your internal fuel and keep moving forward and upward.
Deep Medicine by Eric Topol, The Autobiography of Malcom X (re-read), and The 50th Law by 50 Cent (yes, the rapper) and Robert Greene.